MedPath

Study of Immediate Start of Progestin Contraceptives in Medical Abortion

Phase 4
Completed
Conditions
Contraception
Interventions
Other: Timing of Contraceptive Initiation in Medical Abortion
Registration Number
NCT01902485
Lead Sponsor
Gynuity Health Projects
Brief Summary

This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
937
Inclusion Criteria

Women having medical abortion desiring progestin-based contraceptives (injectables or implants)

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AfterstartTiming of Contraceptive Initiation in Medical AbortionDelayed start
QuickstartTiming of Contraceptive Initiation in Medical AbortionImmediate start
Primary Outcome Measures
NameTimeMethod
Repeat Pregnancy6 months after enrollment
Medical Abortion FailureOne month after enrollment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Bayview Medical Center

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Planned Parenthood of the Pacific Southwest

πŸ‡ΊπŸ‡Έ

Chula Vista, California, United States

Planned Parenthood Northern California

πŸ‡ΊπŸ‡Έ

Eureka, California, United States

Planned Parenthood of Southern New England

πŸ‡ΊπŸ‡Έ

Stamford, Connecticut, United States

Boston Medical Center

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Centro de Salud Beatriz Velasco de Aleman

πŸ‡²πŸ‡½

Mexico City, Mexico

Centro de Salud Santa Catarina

πŸ‡²πŸ‡½

Mexico City, Mexico

Planned Parenthood League of Massachusetts

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Β© Copyright 2025. All Rights Reserved by MedPath